Paolo Cavazza
Net worth: 11 M $ as of 29/04/2024
Health Technology
Profile
Paolo Cavazza worked as a Principal at SciClone Pharmaceuticals LLC.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/06/2023 | 76,580,898 ( 13.01% ) | 11 M $ | 29/04/2024 |
Former positions of Paolo Cavazza
| Companies | Position | End |
|---|---|---|
| SCICLONE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
SciClone Pharmaceuticals LLC
 SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology SciClone Pharmaceuticals LLC was engaged in the development of therapeutic treatment for oncology, infectious diseases, and cardiovascular disorders. It was also offering ZADAXIN for the treatment of hepatitis B, hepatitis C, certain cancers, and used as immune system enhancer, and DC Bead which is used for the novel treatment of liver cancer. The company was founded in 1990 and was headquartered in San Mateo, CA. | Health Technology |
- Stock Market
- Insiders
- Paolo Cavazza
